Peishan Hu

1.3k total citations · 1 hit paper
30 papers, 832 citations indexed

About

Peishan Hu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Peishan Hu has authored 30 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Peishan Hu's work include RNA modifications and cancer (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Peishan Hu is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Peishan Hu collaborates with scholars based in China, United States and Hong Kong. Peishan Hu's co-authors include Zexian Liu, Huai‐Qiang Ju, Qi‐Nian Wu, Rui‐Hua Xu, Heng‐Ying Pu, Jin‐Fei Lin, Xiaozhong Peng, Tao Jiang, Miao‐Zhen Qiu and Boqin Qiang and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Peishan Hu

28 papers receiving 827 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis

2022 226 citations Jin‐Fei Lin, Peishan Hu et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peishan Hu China	16	564	310	172	133	98	30	832
Qianqian Lei China	16	514 0.9×	333 1.1×	213 1.2×	82 0.6×	145 1.5×	39	831
Zhenhua Lin China	17	451 0.8×	189 0.6×	217 1.3×	108 0.8×	105 1.1×	55	814
Yanyan Shen China	21	824 1.5×	293 0.9×	219 1.3×	138 1.0×	120 1.2×	63	1.2k
Xi Yu China	15	410 0.7×	227 0.7×	162 0.9×	101 0.8×	71 0.7×	43	747
Huilin Zheng China	13	719 1.3×	592 1.9×	185 1.1×	80 0.6×	142 1.4×	43	1.1k
Chengyong Dong China	17	387 0.7×	251 0.8×	201 1.2×	100 0.8×	103 1.1×	29	721
Haijun Zhang China	15	544 1.0×	229 0.7×	211 1.2×	154 1.2×	70 0.7×	24	870
Xifa Zhou China	16	583 1.0×	354 1.1×	190 1.1×	104 0.8×	81 0.8×	34	817
Min Kyung Ju South Korea	12	691 1.2×	469 1.5×	365 2.1×	136 1.0×	100 1.0×	16	1.1k
Chiara Ciardiello Italy	11	616 1.1×	300 1.0×	137 0.8×	97 0.7×	88 0.9×	14	773

Countries citing papers authored by Peishan Hu

Since Specialization

Citations

This map shows the geographic impact of Peishan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peishan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peishan Hu more than expected).

Fields of papers citing papers by Peishan Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peishan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peishan Hu. The network helps show where Peishan Hu may publish in the future.

Co-authorship network of co-authors of Peishan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Peishan Hu. A scholar is included among the top collaborators of Peishan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peishan Hu. Peishan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Zerong, Yongqiang Zheng, Yan Hu, et al.. (2025). Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. Gut. 74(6). 884–893. 12 indexed citations

Li, Ting, et al.. (2025). Fatty acid in the tumor microenvironment: Perspectives for immunotherapy. Critical Reviews in Oncology/Hematology. 215. 104878–104878.

Hu, Peishan, et al.. (2024). Point-of-Use SERS Approach for Efficient Determination and Removal of Phthalic Acid Esters Based on a Metal–Organic Framework-Coated Melamine Sponge. ACS Applied Materials & Interfaces. 16(9). 11528–11536. 15 indexed citations

Zhang, Wei, et al.. (2024). Portable SERS-Based POCT Kit for Ultrafast and Sensitive Determining Paraquat in Human Gastric Juice and Urine. ACS Omega. 9(16). 18576–18583. 3 indexed citations

Hu, Chuling, Zhaoliang Yu, Xinxin Huang, et al.. (2024). KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF‑β mediated epithelial‑mesenchymal transition. Molecular Medicine Reports. 31(1). 2 indexed citations

Hu, Yan, Peishan Hu, & Xiaozhong Peng. (2024). Paracrine function amplifies pro-tumor electrochemical signal within neuron-glioma synapses. Science China Life Sciences. 67(6). 1318–1320. 2 indexed citations

Li, Wanru, Nianlu Li, Shunyu Li, et al.. (2023). Rapid identification and quantification of diquat in biological fluids within 30 s using a portable Raman spectrometer. Biosensors and Bioelectronics. 225. 115083–115083. 24 indexed citations

Hu, Peishan, et al.. (2023). TIM-3 blockade: immune and targeted therapy in DIPG. Trends in Molecular Medicine. 30(2). 110–112. 1 indexed citations

Liu, Furong, Xiaoli Wei, Zhanhong Chen, et al.. (2023). PFKFB2 is a favorable prognostic biomarker for colorectal cancer by suppressing metastasis and tumor glycolysis. Journal of Cancer Research and Clinical Oncology. 149(12). 10737–10752. 7 indexed citations

10.

You, Weiqiang, Yufeng Chen, Zerong Cai, et al.. (2022). SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma. Frontiers in Immunology. 13. 864244–864244. 36 indexed citations

11.

Wu, Qi‐Nian, Xiao-Jing Luo, Jia Liu, et al.. (2021). MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1. Cancer Research. 81(10). 2636–2650. 59 indexed citations

12.

Hu, Peishan, Ting Li, Jin‐Fei Lin, et al.. (2020). VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment. Signal Transduction and Targeted Therapy. 5(1). 183–183. 46 indexed citations

13.

Qi, Meng, Yun‐Xin Lu, Zexian Liu, et al.. (2019). IDDF2019-ABS-0316 Long non-coding RNA CRCAL-2 promotes gastric cancer metastasis by activating wnt/beta-catenin pathway via stabilizing the nuclear transport protein RAN. A39.2–A39. 1 indexed citations

14.

Li, Dengke, Yan Hu, Shanshan Li, et al.. (2019). Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9. Oncogene. 38(43). 6898–6912. 33 indexed citations

15.

Hu, Peishan, Shanshan Li, Fan Wu, et al.. (2019). Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D. Cell Death and Disease. 10(1). 25–25. 50 indexed citations

16.

Zhao, Liyun, Dongdong Yang, Xiaokun Ma, et al.. (2019). The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments. Journal of Cancer. 10(10). 2299–2311. 42 indexed citations

17.

Li, Ting, Peishan Hu, Zhixiang Zuo, et al.. (2019). Additional file 10: of METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma. Figshare. 1 indexed citations

18.

Hu, Yan, Dengke Li, Fan Wu, et al.. (2019). The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13. Journal of Clinical Investigation. 129(8). 3072–3085. 39 indexed citations

19.

Li, Ting, Peishan Hu, Zhixiang Zuo, & Huai‐Qiang Ju. (2018). IDDF2018-ABS-0233 N6-adenosine methyltransferase METTL3 promotes tumour metastasis via SOX2 MRNA M6A modification in colorectal carcinoma. A17.1–A17. 1 indexed citations

20.

Han, Wei, Peishan Hu, Fan Wu, et al.. (2018). FHL3 links cell growth and self-renewal by modulating SOX4 in glioma. Cell Death and Differentiation. 26(5). 796–811. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact